Huntington National Bank’s Oramed Pharmaceuticals ORMP Stock Holding History

Huntington National Bank’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.2K	Hold	3,002	–	–	﹤0.01%	1862
2025 Q4	$8.56K	Hold	3,002	–	–	﹤0.01%	1837
2025 Q3	$7.92K	Hold	3,002	–	–	﹤0.01%	1888
2025 Q2	$6.75K	Hold	3,002	–	–	﹤0.01%	1910
2025 Q1	$6.42K	Buy	3,002 +3,000	+150,000%	+$6.92K	﹤0.01%	1902
2024 Q4	$5	Hold	2	–	–	﹤0.01%	3891
2024 Q3	$5	Sell	2 -5,000	-100%	-$12.2K	﹤0.01%	3887
2024 Q2	$12.9K	Hold	5,002	–	–	﹤0.01%	1597
2024 Q1	$14.6K	Hold	5,002	–	–	﹤0.01%	1568
2023 Q4	$11.6K	Hold	5,002	–	–	﹤0.01%	1606
2023 Q3	$13.1K	Hold	5,002	–	–	﹤0.01%	1485
2023 Q2	$17.9K	Sell	5,002 -50	-1%	-$160	﹤0.01%	1388
2023 Q1	$11K	Hold	5,052	–	–	﹤0.01%	1499
2022 Q4	$60.8K	Hold	5,052	–	–	﹤0.01%	926
2022 Q3	$33K	Hold	5,052	–	–	﹤0.01%	1114
2022 Q2	$23K	Hold	5,052	–	–	﹤0.01%	1279
2022 Q1	$44K	Hold	5,052	–	–	﹤0.01%	1101
2021 Q4	$72K	Buy	5,052 +50	+1%	+$1.04K	﹤0.01%	963
2021 Q3	$110K	Buy	+5,002	New	+$85.2K	﹤0.01%	742

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Huntington National Bank's ORMP Position: Q1 2026 in Review

Huntington National Bank held its Oramed Pharmaceuticals (ORMP) position steady in Q1 2026 at 3,002 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Huntington National Bank first reported a position in ORMP in Q3 2021 and has held it in 19 quarters since. The position peaked at $110K in Q3 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

Huntington National Bank held 3,002 shares of Oramed Pharmaceuticals worth $10.2K as of Q1 2026.
Huntington National Bank left its Oramed Pharmaceuticals share count unchanged in Q1 2026.
Oramed Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1862 holding.
Huntington National Bank first reported a position in Oramed Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
Huntington National Bank's Oramed Pharmaceuticals position peaked at $110K in Q3 2021.
64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.